Alpinix connects drug identity, chemical structure, FDA context, and SEC filings in one focused workspace for biotech analysts and research teams.
Start with a drug, compound, ticker, or company. Keep every result tied to the public record that supports it.Source-backed research example
Resolved ingredient
Presentation fixture reviewed against official RxNorm and PubChem records on 19 Jul 2026.
One research system
Resolve the exact drug concept or compound before moving into broader research context.
Review identity, structure, labeling, filings, and regulatory context with clear source boundaries.
Save profiles and notes in a browser-based research library, then return without rebuilding the trail.
Connected research lenses
Search drugs and compounds, inspect structures, labels, classes, related entities, and field-level evidence.
Open MoleculeMove through biotech companies, SEC filings, financial signals, data quality, and separately attributed FDA context.
Open company intelligenceConfiguration example only. Current record availability appears after sign-in.
Built for consequential research
Connect company filings to the drug and regulatory records behind an investment question.
Screen companies and assets while preserving the official records used for each conclusion.
Build a concise research trail that can be revisited, checked, and shared without source ambiguity.
Public records first
Alpinix beta